Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.055 USD | -3.02% | -6.86% | +51.24% |
05-10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
05-08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |